Aprecia names new vice president of Business Development and Alliance Management
6 September 2019 -

Aprecia, the 3DP Pharmaceutical Company, announced yesterday that it has named Kirk Donaldson as its new vice president of Business Development and Alliance Management.

Donaldson will lead the company's business development efforts as it continues to drive global access to its proprietary 3D-printing platform for pharmaceutical development and manufacturing. He joins Aprecia from MEDPACE where he served as the associate director of Account Management. Prior to MEDPACE, he held various management positions at Patheon (Thermo Fisher Scientific), including senior global business/alliance manager. Donaldson started his pharmaceutical career with Prasco, where he served as the manager of Business Analytics.

Chris Gilmore, Aprecia's chief executive officer, said, 'We are excited to add Kirk to our team as we strengthen and expand our strategic partnerships. Aprecia is at an inflection point for partner growth and support, and Kirk's pharmaceutical lifecycle management experience, from drug innovation through product commercialisation, will be critical in guiding Aprecia's approach to partnerships.'